Categorie| Rank | Bedrijf | |
|---|---|---|
| 1 | Fagron (*) | |
| 2 | Fujifilm (**) | |
| 3 | GlaxoSmithKline (GSK) (**) | |
| 4 | Pfizer (**) | |
| 5 | AstraZeneca (**) | |
| 6 | Abbott (**) | |
| 7 | Johnson & Johnson Innovative Medicine (**) | |
| 8 | Bayer (**) | |
| 9 | MSD (**) | |
| 10 | Organon (**) | |
| 11 | Novartis (**) | |
| 12 | Astellas Pharma (**) | |
| Ecologisch | Score | |
| 1 | GlaxoSmithKline (GSK) | |
| 2 | Fujifilm | |
| 3 | Johnson & Johnson Innovative Medicine | |
| 4 | Fagron | |
| 5 | Pfizer | |
| 6 | Bayer | |
| 7 | AstraZeneca | |
| 8 | MSD | |
| 9 | Abbott | |
| 10 | Organon | |
| 11 | Novartis | |
| 12 | Astellas Pharma | |
| Sociaal | Score | |
| 1 | Fagron | |
| 2 | AstraZeneca | |
| 3 | Pfizer | |
| 4 | Bayer | |
| 5 | GlaxoSmithKline (GSK) | |
| 6 | Abbott | |
| 7 | Fujifilm | |
| 8 | MSD | |
| 9 | Novartis | |
| 10 | Organon | |
| 11 | Johnson & Johnson Innovative Medicine | |
| 12 | Astellas Pharma | |
| Governance | Score | |
| 1 | Fagron | |
| 2 | Fujifilm | |
| 3 | Pfizer | |
| 4 | Abbott | |
| 5 | GlaxoSmithKline (GSK) | |
| 6 | AstraZeneca | |
| 7 | Johnson & Johnson Innovative Medicine | |
| 8 | Organon | |
| 9 | MSD | |
| 10 | Bayer | |
| 11 | Astellas Pharma | |
| 12 | Novartis | |
Bij iedere categorie is aangegeven of deze als enabler (*) is onderzocht of als leader (**). Bij een gecombineerde categorie wordt dit per organisatie vermeld.